Full Breakdown
Rat Seen Swimming in Gulab Jamun Vessel Prompts Maharashtra FDA Raid
By Drooid · · How we work
Core Event
A video showing a rat swimming among gulab jamuns in a sugar-syrup vessel at Harish Gulab Jamun on Naga Road, Shanti Nagar, Bhiwandi (Thane district) went viral on social media. After the clip circulated, the Maharashtra Food and Drug Administration (FDA) raided the shop on Tuesday, October 6, and issued a stop-business notice pending further investigation.
Background of Recent Food-Safety Enforcement
The raid follows a broader crackdown by the state FDA on establishments that violate hygiene standards. Earlier in the month, the agency suspended the licences of eight eateries, seized 1.3 tonnes of chemically ripened bananas, confiscated banned gutkha and adulterated milk in Navi Mumbai, and seized prohibited food products worth Rs 31.14 lakh from three Mumbai establishments, according to a PTI report. The same enforcement drive also led to the arrest of three individuals and the discovery of a dead rat inside a Mysore Masala Dosa in Mumbai.
Official Response from Thane FDA
Santosh Sirosiya, Assistant Commissioner of the Thane FDA (the jurisdiction covering Bhiwandi), told The Indian Express that the authority acted after viewing the viral reel on October 6. The department’s statement emphasized that the stop-business notice was issued to protect public health while a detailed inspection is conducted.
Scope of the Enforcement Action
The FDA’s on-site team inspected the premises, documented the presence of the rodent, and secured the affected food items. The shop has been ordered to remain closed until the investigation is completed and corrective measures are verified. No further legal actions or penalties have been disclosed at this stage.
Potential Implications for Food Vendors
The incident underscores heightened regulatory scrutiny of food-service outlets in Maharashtra. Vendors are being reminded to maintain strict sanitation protocols, as viral evidence can trigger immediate enforcement. Continued monitoring by the FDA may lead to additional inspections and possible closures for non-compliant establishments.